Cite
HARVARD Citation
Seino, Y. et al. (2021). A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin. Diabetes, obesity & metabolism. 23 (6), pp. 1342-1350. [Online].